SS-31 Purity Standards & COA Requirements

Evaluating SS-31 (Elamipretide) for preclinical mitochondrial research requires rigorous verification of peptide identity, chemical purity, and endotoxin levels. This guide outlines the essential analytical parameters, reverse-phase HPLC chromatograms, mass spectrometry standards, and Certificate of Analysis (COA) benchmarks necessary to ensure reproducible experimental outcomes in laboratory settings.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

Evaluating SS-31 (Elamipretide) for preclinical mitochondrial research requires rigorous verification of peptide identity, chemical purity, and endotoxin levels. This guide outlines the essential analytical parameters, reverse-phase HPLC chromatograms, mass spectrometry standards, and Certificate of Analysis (COA) benchmarks necessary to ensure reproducible experimental outcomes in laboratory settings.

Reviewed by PX1 Research scientific team

Key takeaways

  • [SS-31](/research-peptides/ss-31) (also known as Szeto-Schiller peptide 31 or Elamipretide) is a synthetic tetrapeptide widely utilized in mitochondrial research and bioenergetic assays.
  • Chemically, [SS-31](/research-peptides/ss-31) is structured as D-Arg-Dmt-Lys-Phe-NH2, incorporating alternating aromatic residues and basic amino acids with a modified 2',6'-dimethyl-L-tyrosine (Dmt) residue at position 2.
  • Purity assessment for [SS-31](/research-peptides/ss-31) relies primarily on Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC).
  • Bacterial endotoxins (lipopolysaccharides, LPS) present a severe confounding factor in cellular assays, primary mitochondrial isolations, and animal studies.

Introduction to SS-31 Analytical Standards in Mitochondrial Research

SS-31 (also known as Szeto-Schiller peptide 31 or Elamipretide) is a synthetic tetrapeptide widely utilized in mitochondrial research and bioenergetic assays. Because SS-31 directly interacts with cardiolipin within the inner mitochondrial membrane in cell culture and animal models, subtle chemical impurities or batch variations can dramatically alter experimental results. Sub-standard reagents introduce non-specific cytotoxic effects, false bioenergetic readings, or off-target signaling events that compromise data integrity.

To establish reproducible experimental baselines, analytical laboratories must require comprehensive validation for every lot of SS-31 research peptide. This documentation must detail high-performance liquid chromatography (HPLC) purity, mass spectrometry (MS) exact mass identity, residual trifluoroacetate (TFA) content, and bacterial endotoxin levels. The following analysis defines the analytical standards required for research-grade SS-31 and demonstrates how to interpret a comprehensive Certificate of Analysis (COA).

Chemical Architecture and Identity Verification of SS-31

Chemically, SS-31 is structured as D-Arg-Dmt-Lys-Phe-NH2, incorporating alternating aromatic residues and basic amino acids with a modified 2',6'-dimethyl-L-tyrosine (Dmt) residue at position 2. Its exact molecular formula is C32H49N9O5, yielding a monoisotopic molecular weight of 639.38 g/mol (free base equivalent mass). The inclusion of non-canonical and D-amino acid configuration confers structural resistance to standard aminopeptidases, a crucial feature routinely examined in preclinical research protocols.

Identity verification requires high-resolution Mass Spectrometry (MS). Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) must exhibit a predominant protonated molecular ion peak [M+H]+ at m/z 640.4 ± 0.5 Da, as well as doubly charged species [M+2H]2+/2 at m/z 320.7. Any secondary peaks exceeding 1% relative intensity suggest incomplete side-chain deprotection, sequence truncation, or synthesis side-products that necessitate lot rejection.

High-Performance Liquid Chromatography (HPLC) Purity Thresholds

Purity assessment for SS-31 relies primarily on Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). Because SS-31 contains basic amino acid residues (Arginine and Lysine) alongside hydrophobic aromatic rings, specialized column chemistry and elution gradients are required to achieve adequate chromatographic resolution.

Analytical RP-HPLC protocols typically utilize C18 stationary phases (e.g., 4.6 mm × 250 mm, 5 µm particle size) with a binary gradient of Water/Acetonitrile containing 0.1% Trifluoroacetate (TFA) or Formic Acid as an ion-pairing agent. Detection is routinely monitored at 220 nm (peptide backbone absorption) and 280 nm (aromatic side-chain absorption of Dmt and Phe).

For rigorous in vitro and animal models, research facilities should insist on a minimum HPLC purity threshold of ≥98.0%. In the resulting chromatogram, the area under the curve (AUC) of the principal peak corresponding to SS-31 must represent at least 98% of total integrated peak area. Chromatographic impurities—such as deletion peptides missing the Lys or Phe residues—must be quantified and individually remain below 0.5% total peak area.

Endotoxin Limits and Quantification Methods

Bacterial endotoxins (lipopolysaccharides, LPS) present a severe confounding factor in cellular assays, primary mitochondrial isolations, and animal studies. LPS contamination triggers Toll-like receptor 4 (TLR4) activation, inducing inflammatory cascades, altering mitochondrial membrane potential, and confounding bioenergetic measurements independently of SS-31 mechanism.

Quantification of endotoxin content must be conducted via a validated Limulus Amebocyte Lysate (LAL) assay, such as the chromogenic or turbidimetric kinetic method. Standard research-grade peptide specifications often tolerate up to 10 EU/mg, but high-tier mitochondrial reagents require significantly stricter thresholds. PX1 Research enforces an endotoxin standard of <0.05 EU/mg for all research peptides. Ensuring endotoxin levels fall below this baseline prevents immune activation artifacts in isolated cardiomyocyte, neural, or renal cell cultures.

Counter-Ion Determination and Residual Solvents

During solid-phase peptide synthesis (SPPS), final cleavage from resin utilizes high concentrations of trifluoroacetate (TFA). Consequently, raw SS-31 exists as a TFA salt. Unmodified TFA counter-ions can exert cytotoxic effects in cell culture models, uncoupling oxidative phosphorylation or destabilizing physiological buffer pH when reconstituted at millimolar concentrations.

A rigorous Certificate of Analysis reports counter-ion identity and residual TFA content. Analytical laboratories utilize Ion Chromatography (IC) or RP-HPLC with specialized mobile phases to quantify TFA content. For sensitive in vitro applications, TFA exchange to an acetate salt form or reduction of residual TFA to <1.0% by weight is highly desirable. Additionally, Gas Chromatography with Flame Ionization Detection (GC-FID) or Headspace GC-MS should verify that residual organic solvents (such as acetonitrile, dimethylformamide, or dichloromethane) remain strictly within ICH Q3C guidelines.

Deconstructing the PX1 Research Certificate of Analysis (COA)

Every batch of SS-31 distributed by PX1 Research undergoes testing in an ISO 17025 accredited, independent analytical facility. The resulting COA provides researchers with total transparency and objective verification prior to initiating experimental protocols. You can request batch-specific COAs directly through our wholesale and lab account support.

A compliant PX1 Research COA for SS-31 includes:

• Lot Identification: Unique lot/batch tracking matching the vial label.

• Physical Appearance: Description of the lyophilized cake (white to off-white powder).

• Identity Confirmation: High-resolution ESI-MS spectrum confirming exact mass matching theoretical 639.38 Da.

• Purity Profile: RP-HPLC chromatogram with peak integration table verifying ≥98% purity.

• Endotoxin Content: LAL kinetic chromogenic assay results confirming <0.05 EU/mg.

• Peptide Content / Net Peptide Purity: Nitrogen analysis or elemental analysis quantifying active peptide content vs. moisture/counter-ions.

• Solubilization & Clear Solution Test: Verification of rapid, complete dissolution in sterile water or buffered saline.

Comparative Analytical Framework: SS-31 vs. Related Mitochondrial Peptides

When designing mitochondrial bioenergetic studies, researchers often evaluate SS-31 alongside other mitochondria-targeted compounds such as MOTS-c peptide, Humanin, or various mitochondrial-derived peptides (MDPs). Each peptide presents distinct chemical attributes and analytical challenges during purity testing.

For instance, while SS-31 is a basic tetrapeptide (MW ~639.8 g/mol) requiring ion-pairing agents for HPLC separation, MOTS-c is a 16-amino-acid peptide (MW ~2174.5 g/mol) with greater hydrophobic character, requiring broader organic solvent gradients during RP-HPLC. Similarly, Humanin is a 24-amino-acid peptide prone to aggregation in aqueous solutions, necessitating specialized dissolution testing and secondary structure evaluation. Ensuring high analytical purity across all compounds in a comparative study is critical to isolate specific pathways without interference from synthetic fragments or endotoxin artifacts.

Laboratory Reconstitution and Storage Guidelines

Proper handling of research-grade SS-31 is vital to prevent chemical degradation, oxidation, or peptide aggregation after receipt. Lyophilized SS-31 should be stored at -20°C or -80°C in a desiccated environment upon arrival. Under these conditions, the dry peptide remains stable for extended periods without loss of purity.

For laboratory reconstitution, vials should be equilibrated to room temperature prior to opening to prevent atmospheric moisture condensation on the lyophilized cake. Dissolve SS-31 in sterile, deionized research-grade water or sterile phosphate-buffered saline (PBS, pH 7.4). For long-term cell culture studies, aliquoting the stock solution into single-use microcentrifuge tubes and storing at -80°C minimizes freeze-thaw cycles, which can cause peptide cleavage or physical precipitation. Avoid vortexing vigorously; gentle inversion or light sonication is recommended.

PX1 Research Supply Chain Integrity and Quality Guarantee

PX1 Research is dedicated to supporting US-based academic institutions, biotechnology companies, and contract research organizations with verified, high-purity research compounds. All peptides are synthesized in state-of-the-art, GMP-compliant facilities and tested in accredited ISO 17025 testing laboratories.

Every batch of SS-31 purity verified reagent ships directly from our California and Arizona fulfillment centers with same-day dispatch for orders placed Monday through Friday. By maintaining full lot traceability and transparent third-party analytical documentation, PX1 Research empowers scientists to execute precise, reproducible preclinical research with total confidence in reagent quality.

Frequently Asked Questions

What is the minimum recommended HPLC purity threshold for SS-31 in research?

For cell culture, isolated organelle, and animal model research, laboratories should require a minimum RP-HPLC purity of ≥98.0%. Lower purity grades may introduce truncated peptide fragments that interfere with cardiolipin binding or mitochondrial respiration assays.

How is the identity of SS-31 verified on a COA?

Identity is verified via Mass Spectrometry (ESI-MS or MALDI-TOF). The observed molecular mass must match the theoretical molecular weight of SS-31 (639.38 g/mol for free base) within standard instrument mass tolerance (typically ±0.5 Da).

What endotoxin limit does PX1 Research guarantee for SS-31?

PX1 Research enforces a strict endotoxin standard of <0.05 EU/mg for SS-31, tested via kinetic chromogenic LAL assay. This minimizes inflammatory signaling or TLR4 activation in cellular and preclinical models.

Why is TFA counter-ion testing important for SS-31?

Trifluoroacetate (TFA) is used during peptide cleavage and purification. Excessive residual TFA can drop buffer pH and cause non-specific cytotoxicity in cell culture assays. COA reporting ensures TFA content is monitored and controlled.

How should lyophilized SS-31 be stored in the lab?

Lyophilized SS-31 should be kept at -20°C or -80°C in a desiccated container. Reconstituted stock solutions should be aliquoted and frozen at -80°C to avoid repeated freeze-thaw cycles.

What solvents are suitable for reconstituting SS-31 for in vitro assays?

SS-31 is highly soluble in sterile research-grade water, normal saline (0.9% NaCl), or standard PBS (pH 7.4). Avoid high concentrations of organic solvents unless required by specific experimental protocols.

Can I obtain a lot-specific COA for my SS-31 order?

Yes. PX1 Research provides third-party ISO 17025 accredited COAs detailing HPLC chromatograms, MS spectra, and LAL endotoxin testing for every single production lot.

How does SS-31 compare analytically to MOTS-c or Humanin?

SS-31 is a compact, highly basic tetrapeptide requiring specialized ion-pairing RP-HPLC, whereas MOTS-c and Humanin are longer peptides with higher molecular weights and different hydrophobic profiles requiring broader solvent elution gradients.

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.